Changes on the Executive Board

Dr Andreas Mayr assumes additional responsibility within Endress+Hauser; Jörg Stegert joins the Group to head up human resources  Change is taking place at the top of the Endress+Hauser Group. Effective 1 March 2019, Dr Andreas Mayr will become Chief Operating Officer (COO) responsible for sales, production and support, thus assuming more responsibility on the Executive... Read more

Xylem Inc. to present at the BMO Capital Markets 2018 Boston Growth Conference

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 29, 2018– Xylem Inc. (NYSE:XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, announced today that its Senior Vice President of Continuous Improvement and Business Transformation, Tony Milando, and Senior Director, Investor Relations, Matthew Latino, will participate in group discussions at the BMO Capital... Read more

German Scientist Wins 2018 Eppendorf & Science Prize

11/28/2018 German scientist Johannes Kohl, Ph.D. has won the Prize for his work on neural mechanisms underlying parental care. Johannes Kohl carried out his research in the laboratory of Catherine Dulac at Harvard University. His work has revealed how a small population of genetically defined neurons controls the motor, motivational, hormonal, and social aspects of... Read more

Laboratory Products Association nominates Ryan Titmas to Board of Directors

Middleton, WI (November30, 2018) Gilson announced today that Ryan Titmas, Vice President of Sales for the Americas, has started a three-year tenure on the Board of Directors for the Lab Product Association (LPA). Titmas brings nearly 20 years of experience in sales management and distribution relationship management experience in laboratory equipment and the life science consumables marketplace. The LPA nomination... Read more

MilliporeSigma Wins Two R&D 100 Awards for Innovation in 2018

27 NOV 2018 | DARMSTADT, GERMANY MilliporeSigma’s proxy-CRISPR wins Special Recognition Market Disruptor — Products award Burlington, Massachusetts, November 27, 2018 – MilliporeSigma today announced that it has won two R&D 100 Awards. The 56th annual R&D 100 Awards program, honoring the 100 most innovative and significant technologies introduced in the past year, recognized MilliporeSigma for its BioReliance® Viral and Gene Therapy Assay... Read more

Appointment of Non-Executive Chairman

26 November 2018 Oxford Instruments plc, a leading provider of high-technology products, systems and tools for industry and research, today announces the appointment of Neil Carson as Non-Executive Chairman.  He will join the Board with effect from 1st December 2018. Neil Carson is an experienced Chairman and Non-Executive Director.  He is currently Chairman of TT... Read more

LGC acquires Seracare Life Sciences, strengthening its position in clinical quality control tools

26 NOV 2018 Today, LGC announced the acquisition of SeraCare Life Sciences, Inc., a manufacturer and leading partner to global in vitro diagnostics manufacturers and clinical laboratories. SeraCare provides quality control materials for infectious disease testing through their ACCURUN® reagents as well as in the fast growing clinical next-generation sequencing (NGS) market which it addresses through... Read more

Twist Bioscience Appoints Experienced Technology Executive Jan Johannessen to Board of Directors

November 26, 2018 05:00 AM Pacific Standard Time SAN FRANCISCO–(BUSINESS WIRE)–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced the appointment of Jan Johannessen to the company’s board of directors. He will also serve as chair of the audit committee. Mr. Johannessen brings more... Read more

Fluidic Analytics raises $31m to launch two new products in lab tools pipeline and unlock biology behind major diseases

Cambridge, UK – (26 November 2018) – Fluidic Analytics Ltd has raised $31 million to continue developing its transformational products for characterising proteins and their behaviour. The proceeds of the financing will be used to continue the commercial roll-out of the company’s lab-tools pipeline and to develop further high-value clinical applications of its technology. Proteins and their behaviour... Read more